News | July 08, 2008

Confirma Offers CME Programs for Breast MRI

July 9, 2008 — Confirma is expanding customer support by providing increased access to CME-accredited educational programs for physicians to meet the growing demand for breast MRI.

Confirma supports professional development in breast MRI through educational grants to organizations, including the International Center for Postgraduate Medical Education (ICPME) and The Scienomics Group. Education programs consist of a variety of online case review seminars, fellowships, and didactic and hands-on training workshops.

The hands-on courses, supported by Confirma, are intended to educate physicians and technologists who offer breast MRI examinations and perform MRI-guided breast biopsies. Educational objectives include: assessing the clinical role of breast MRI in patient selection and the detection, diagnosis and management of breast disease; developing standardized post-processing techniques to determine the morphology and kinetics of lesions in breast MRI; and accurately interpreting and reporting breast MR images in accordance with the ACR BI-RADS. Participants also have the opportunity to review cases using CAD and practice MRI-guided biopsy techniques using a breast biopsy system.

Confirma is also providing a grant along with Bayer Healthcare for a new educational program, Breast MRI Interpretation for Radiologists, led by Constance D. Lehman, M.D., Ph.D., director of radiology at the Seattle Cancer Care Alliance and professor of radiology at the University of Washington, and Gillian M. Newstead, M.D., professor of radiology and director of breast imaging at the University of Chicago.

For more information: http://www.confirma.com/edu-train_calendar.html

Related Content

Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
SimonMed Deploys ClearRead CT Enterprise Wide
News | Computer-Aided Detection Software | September 17, 2018
September 17, 2018 — National outpatient physician radiology group SimonMed Imaging has selected Riverain Technologie
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
FDA Issues Proposed Order to Reclassify Certain Radiological Medical Image Analyzers
News | Computer-Aided Detection Software | June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical...
Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
FDA Clears First AI-Powered Clinical Decision Support Software for Stroke
Technology | Clinical Decision Support | February 14, 2018
The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first ...